Keio Innovation Initiative is a brand-new company record, and its full research profile isn't ready yet.
keio-innovation.co.jpCrawled Oct 26, 2026
Building on research at Keio University, the company develops graphene device technology and optical device applications.
KII invests in academic research and innovations to bridge gaps between academia and business for societal impact.
The startup is certified by the National Institutes for Quantum Science and Technology (QST).
Collaborating with RIKEN, the company achieves high-power, compact, and highly efficient space lasers.
The page discusses challenges in maintaining numerous sensors amid the rise of IoT and automation in manufacturing.
The page explores the potential of HGF (hepatocyte growth factor) in treating intractable diseases by leveraging the liver’s regenerative capacity.
The page features interviews with venture companies supported by KII, including the first IPO from its third Impact Fund.
The page highlights the unmet medical needs of stroke patients suffering paralysis and severe sequelae.
The page details KII’s sponsorship of the ICC Summit Kyoto 2026, where its deep-tech session won recognition from industry experts.
The page notes KII’s participation as an official sponsor at the Japan Healthcare Venture Summit 2026, featuring medical venture presentations.
The page announces a session by Senior Associate Suzuki at the New Business Grand Conference 2026, focusing on commercializing deep-tech from universities.
The page announces a special lecture by Principal Torii at Hokkaido University on career planning and university life.
The page lists a team member’s background: a graduate of Waseda University’s School of Social Sciences with experience at Deloitte Touche Tohmatsu.
The page outlines a team member’s academic and professional history, including a degree from Keio University’s Faculty of Literature and prior roles at Advflex Communications.
The page highlights a team member’s focus on technology investments, with education from Waseda University’s Faculty of Law and Tokyo University’s Graduate School of Public Policy.
The page details a team member’s expertise in life sciences investment, with a background in Kyoto University’s Faculty of Science and Graduate School of Medicine.
Keio Innovation Initiative bridges academia and business to help university-born technologies grow into socially impactful ventures.